Our client is an American publicly traded global biopharmaceutical company in the top Fortune 500!
They are a company that takes on the toughest health challenges. But do more than treat diseases—they aim to make a remarkable impact on people’s lives.
They have invested approximately $50 billion in research to discover, develop and deliver new medicines. They target diseases with significant unmet need where they can improve the standard of care with innovative new therapies.
With ~50,000 employees around the world, they focus on discovering and delivering transformational medicines and products in several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women’s health.